Status:
COMPLETED
Study of Responsiveness of Seven Functional Tasks in Patients With Poststroke Upper Limb Spasticity With Botulinum Toxin Type A Treatment
Lead Sponsor:
Allergan
Conditions:
Stroke
Muscle Spasticity
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This study evaluates the responsiveness of 7 functional tasks to botulinum toxin Type A treatment in poststroke patients with spasticity of the upper-limb flexors
Eligibility Criteria
Inclusion
- Medically stable poststroke with focal unilateral upper-limb spasticity
Exclusion
- Stroke within 6 months of the study enrollment visit
- Previous or current botulinum toxin therapy of any type in the study limb
Key Trial Info
Start Date :
March 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2005
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT00651690
Start Date
March 1 2004
End Date
May 1 2005
Last Update
May 28 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Indianapolis, Indiana, United States